Adtalem Global Education

Adtalem Global Education, Inc. engages in the provision of workforce solutions. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers more than 100 online certificate, bachelor’s, master’s, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment consists of degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Adtalem Global Education reports Q1 revenue growth and enrollment challenges

Adtalem Global Education's Q1 2023 performance reflects revenue growth, strong cash flow generation, and strategic initiatives to address workforce challenges in the healthcare system. While facing enrollment declines at Walden, the company made significant progress in marketing capabilities and student support at Chamberlain and Med/Vet. The narrowed guidance range for fiscal year 2023 revenue indicates a need to address enrollment challenges at Walden.

Adtalem Global Education reports solid Q2 results and growth outlook

Adtalem Global Education's Q2 performance reflects a mix of strengths and challenges across its segments. The company remains focused on enhancing student experience and optimizing marketing efforts. With a solid outlook for fiscal 2023, Adtalem is poised for continued growth and success.

Adtalem Global Education reports Q3 growth, eyes healthcare education opportunities

Adtalem Global Education's Q3 performance showed revenue growth, strong financial metrics, and segment-specific highlights. While facing challenges in certain segments, the company is leveraging opportunities in healthcare education and brand enhancement to drive sustainable growth.

Adtalem Global Education reports robust Q4 earnings and optimistic outlook

Adtalem Global Education's Q4 2023 performance reflects strong financial results, successful strategic initiatives, and a positive outlook for fiscal year 2024. The company faces challenges in the Med/Vet segment but is proactively addressing them to improve enrollment trends. Opportunities for growth and improvement are being pursued through strategic investments and leveraging positive enrollment trends.

Adtalem Global Education exceeds Q1 expectations, focuses on growth

Adtalem Global Education's Q1 2024 performance showcased revenue and EPS growth, driven by the Growth with Purpose strategy and strong performance in key segments.
While facing challenges in the Med/Vet segment and competitive pressures, the company's focus on brand campaigns and student experience enhancements yielded positive results.
Guidance for fiscal 2024 indicates a strategic outlook for continued growth, improved enrollment trends, and revenue acceleration in the latter part of the year.
By capitalizing on strengths, addressing challenges, and exploring opportunities, Adtalem is poised for sustained growth and performance enhancements in the education sector.

Adtalem Global Education excels in Q2, raises guidance for FY 2024

Adtalem Global Education's Q2 earnings call showcased robust financial performance, strategic investments in academic quality, and confidence in future growth. Despite challenges like addressing short seller reports, the company's strengths in key divisions and capital allocation actions position it well for continued success.

Adtalem Global Education excels in Q3, eyes leadership in education and healthcare

Adtalem Global Education delivered a strong performance in Q3 2024, with notable growth in enrollment, revenue, and earnings per share, showcasing its operational excellence.
The company's strategic focus on education and healthcare sectors positions it well for future growth and leadership in the industry.
With raised revenue guidance and a commitment to academic quality, Adtalem is poised to capitalize on opportunities for expansion and innovation in the coming quarters.

Adtalem Global Education excels in Q4 2024, projects growth

Adtalem Global Education's Q4 2024 performance showcased robust financial results and operational achievements.
The company's strategic focus on growth, student outcomes, and capital allocation balance underpins its success.
While challenges like maintaining enrollment growth persist, Adtalem is well-positioned to leverage opportunities for expansion.
Overall, Adtalem's strong performance and positive outlook signal a promising trajectory for future growth and success.

Adtalem Global Education (ATGE) reports stellar Q1 results and eyes strategic growth opportunities

Adtalem Global Education (ATGE) excelled in Q1 2025, demonstrating robust financial performance and enrollment growth. While facing challenges in marketing expense timing, the company is well-positioned to capitalize on opportunities to strengthen its market position and drive continued growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.

Grand Canyon Education

Investors looking for stocks in the Schools sector might want to consider either Adtalem Global Education (ATGE) or Grand Canyon Education (LOPE). But which of these two stocks offers value investors a better bang for their buck right now?

ATGE vs. LOPE: Which Stock Is the Better Value Option?

NEW YORK , March 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Adtalem Global Education, Inc. ("Adtalem" or the "Company") (NYSE: ATGE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adtalem Global Education, Inc. - ATGE

CHICAGO--(BUSINESS WIRE)--Adtalem honors 5.5K+ Walden graduates, new wave of professionals emerge ready to address healthcare workforce shortage.

Adtalem Global Education Honors Over 5,500 Graduates at Walden University's 70th Commencement

Adtalem (ATGE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Adtalem (ATGE) Loses -25.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CHICAGO--(BUSINESS WIRE)--Adtalem CEO Steve Beard and CFO Bob Phelan will participate in a fireside chat at the Morgan Stanley TMT Conference on March 6 at 1:20 p.m. PT.

Adtalem Global Education to Present at Morgan Stanley Technology, Media and Telecom Conference

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education has appointed Scott Liles as president, Adtalem medical and veterinary, effective April 1.

Adtalem Global Education Names Scott Liles as the New Medical and Veterinary President

LOS ANGELES, CA / ACCESSWIRE / February 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. ("Adtalem" or "the Company") (NYSE:ATGE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adtalem Global Education Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. ("Adtalem" or "the Company") (NYSE:ATGE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adtalem Global Education Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. ("Adtalem" or "the Company") (NYSE:ATGE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adtalem Global Education Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. ("Adtalem" or "the Company") (NYSE:ATGE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adtalem Global Education Inc. and Encourages Investors with Losses to Contact the Firm

The heavy selling pressure might have exhausted for Adtalem (ATGE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

After Plunging -21.09% in 4 Weeks, Here's Why the Trend Might Reverse for Adtalem (ATGE)

Adtalem Global Education Inc. (ATGE) Q4 2023 Earnings Call Transcript

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education, Inc. (NYSE: ATGE) responds to claims in a report released on January 30 from Safkhet Capital. “The report contains numerous factual errors, demonstrates a poor understanding of our industry as well as rudimentary transaction accounting, and is a reckless attempt to defame the nation's largest healthcare educator,” said Adtalem President and CEO Steve Beard. Safkhet Capital's inability to accurately state even the most basic facts undermines th.

Adtalem Global Education Counters Safkhet Capital Report

LOS ANGELES, CA / ACCESSWIRE / January 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. ("Adtalem" or "the Company") (NYSE:ATGE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adtalem Global Education Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Adtalem Global Education Inc. (“Adtalem” or the “Company”) (NYSE: ATGE) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Adtalem investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secu.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Adtalem Global Education Inc. (ATGE) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Adtalem Global Education Inc. (“Adtalem” or the “Company”) (NYSE: ATGE) investors concerning the Company's possible violations of federal securities laws. On January 30, 2024, Safkhet Capital Research published a report alleging, among other things, that Adtalem's business model is “fast and loose admissions made possible by aggressive and sometimes deceptive tactics,” specifying that Adtalem.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Adtalem Global Education Inc. (ATGE) on Behalf of Investors

Microsoft

Pfizer

To be blunt, buying a Wall Street recommended stock can be a mixed bag. While we trust experts in say the legal and medical fields, it's a different proposition in the equities space.

Listen to Wall Street and Buy These 3 Stocks Now

Adtalem's (ATGE) second-quarter fiscal 2024 results reflect impressive enrollment growth along with the consistent execution of the Growth with Purpose strategy.

Adtalem (ATGE) Q2 Earnings & Revenues Top, '24 View Raised

Adtalem Global Education (ATGE) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.17 per share a year ago.

Adtalem Global Education (ATGE) Surpasses Q2 Earnings and Revenue Estimates

OAKLAND, Calif.--(BUSINESS WIRE)---- $ATGE #ATGE--Gibbs Law Group is investigating potential legal claims on behalf of Adtalem Global Education, Inc. (NYSE: ATGE). Contact: (888) 410-2925.

Lost Money in Adtalem Global Education? Gibbs Law Group Investigates Potential Securities Law Violations

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE) today reported second quarter fiscal 2024 results (ended Dec. 31, 2023) reflecting accelerated total enrollment and revenue growth, underpinned by strong profitability and high-quality academic outcomes through executing Growth with Purpose strategy. “Adtalem once again performed ahead of expectations this quarter, solidifying our position as a leading healthcare educator,” said Steve Beard, president, and chief executive offi.

Adtalem Global Education Fiscal Second Quarter 2024 Results; Guidance Raised

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Adtalem Global Education Inc. (“Adtalem” or the “Company”) (NYSE: ATGE) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On January 30, 2024, Safkhet Capital Research published a report alleging, among other things, that Adtalem's business model is “fast and loose admissions made possi.

The Law Offices of Frank R. Cruz Announces Investigation of Adtalem Global Education Inc. (ATGE) on Behalf of Investors

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, announced today it will release its fiscal 2024 second quarter results, ahead of schedule, on Tuesday, January 30, 2024, after financial markets close. The company's earnings announcement was originally scheduled for Thursday, February 1, 2024. In light of market news today, Adtalem has rescheduled its earni.

Adtalem Global Education to Announce Fiscal Second Quarter 2024 Results After Market Close Today

Fahmi Quadir just targeted Adtalem Global Education Inc (NYSE: ATGE) in her latest short-seller report. Shares of the education company opened nearly 20% down on Tuesday.

Adtalem stock targeted in a new short seller report

Quadir predicts that Adtalem is wasting federal tax dollars on programs that are ineffective, and that it faces several significant financial threats.

News for Adtalem Global Education Stock (ATGE)